User of angiotensin-converting-enzyme inhibitor and/or angiotensin II receptor blocker might be associated with vascular calcification in predialysis chronic kidney disease patients: a retrospective single-center observational study: ACEI/ARB and vascular calcification

BACKGROUND: Vascular calcification is a prominent feature in chronic kidney disease (CKD) and diabetes mellitus. A recent report suggests that angiotensin II is protective to vascular calcification. Therefore, we investigated the relationship between vascular calcification and use of angiotensin-con...

Descripción completa

Detalles Bibliográficos
Autores principales: Takaori, Kaori, Iwatani, Hirotsugu, Yamato, Masafumi, Ito, Takahito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789142/
https://www.ncbi.nlm.nih.gov/pubmed/33407242
http://dx.doi.org/10.1186/s12882-020-02198-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789142/
https://www.ncbi.nlm.nih.gov/pubmed/33407242
http://dx.doi.org/10.1186/s12882-020-02198-6

Ejemplares similares